Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.78 |
| ▸ | ESR1 | P03372 | 1/20 | 0.78 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.78 |
| ▸ | LTA4H | P09960 | 7/20 | 0.64 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.64 |
| ▸ | BAX | Q07812 | 1/20 | 0.64 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3175106 | 0.88 | ESR2 (1.00) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL249169 | 0.88 | ESR2 (1.00) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL7811939 | 0.88 | ESR2 (1.00) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL18198 | 0.88 | ESR2 (1.00) | MEN1KMT2AESR1ESR2LTA4H | |
| Di(Hydroxyethyl)Ether SCHEMBL2471329 | 0.85 | MEN1 (0.64) | MEN1KMT2AESR1ESR2LTA4H | |
| Hydrogen Sulfide SCHEMBL27529439 | 0.85 | MEN1 (0.93) | MEN1KMT2AESR1ESR2LTA4H | |
| Water SCHEMBL8862151 | 0.85 | MEN1 (0.93) | MEN1KMT2AESR1ESR2LTA4H | |
| Bromide SCHEMBL11037542 | 0.82 | MEN1 (0.88) | MEN1KMT2AESR1ESR2LTA4H | |
| SCHEMBL5124930 | 0.82 | LTA4H (0.68) | MEN1KMT2AESR1ESR2LTA4H | |
| Hydroquinone SCHEMBL10547720 | 0.82 | ALDH1A1 (0.67) | MEN1KMT2AESR1ESR2NR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577391-B2 | Chemically-resistant flame retardant compositions | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2026-03-17 | — | — | US | disclosed |
| US-20250002717-A1 | THERMOPLASTIC COMPOSITIONS AND USES THEREOF | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-01-02 | — | — | US | disclosed |
| US-20240101819-A1 | CURABLE COMPOSITION CONTAINING CYCLIC MULTIFUNCTIONAL MONOMER | TOKUYAMA CORPORATION (JP) | 2024-03-28 | — | — | US | disclosed |
| US-20240101751-A1 | HOLLOW MICROBALLOON | TOKUYAMA CORPORATION (JP) | 2024-03-28 | — | — | US | disclosed |
| US-20240084067-A1 | NOVEL CURABLE COMPOSITION CONTAINING CYCLIC MONOMER | TOKUYAMA CORPORATION (JP) | 2024-03-14 | — | — | US | disclosed |
| US-20230390890-A1 | POLYMERIZABLE FUNCTIONAL GROUP-CONTAINING MICROBALLOON | TOKUYAMA CORPORATION (JP) | 2023-12-07 | — | — | US | disclosed |
| EP-4286435-A1 | NOVEL CURABLE COMPOSITION CONTAINING CYCLIC MONOMER | Tokuyama Corporation (JP) | 2023-12-06 | — | — | EP | disclosed |
| EP-4286439-A1 | HOLLOW MICROBALLOON | Tokuyama Corporation (JP) | 2023-12-06 | — | — | EP | disclosed |
| EP-4286442-A1 | CURABLE COMPOSITION CONTAINING CYCLIC MULTIFUNCTIONAL MONOMER | Tokuyama Corporation (JP) | 2023-12-06 | — | — | EP | disclosed |
| WO-2023167294-A1 | METHOD FOR PRODUCING HOLLOW MICROPARTICLES USING SUPERCRITICAL LIQUID | 株式会社トクヤマ | 2023-09-07 | — | — | WO | disclosed |
| US-4743676-A | Method for preparing polycarbonate of controlled molecular weight from aromatic bischloroformate | GENERAL ELECTRIC COMPANY (US) | 1988-05-10 | — | — | US | disclosed |
| EP-0264835-A2 | Cyclic polyester oligomers and methods for their preparation and use | GENERAL ELECTRIC COMPANY (US) | 1988-04-27 | — | — | EP | disclosed |
| US-4740583-A | Method for converting cyclic polycarbonate oligomer mixtures to linear polycarbonate, and composition resulting therefrom | GENERAL ELECTRIC COMPANY (US) | 1988-04-26 | — | — | US | disclosed |
| EP-0263432-A1 | Method for preparing aromatic bischloroformate compositions and polycarbonates | GENERAL ELECTRIC COMPANY (US) | 1988-04-13 | — | — | EP | disclosed |
| US-4737573-A | USING PHOSGENE, DIHYDROXY COMPOUND, WATER AND AN INERT ORGANIC LIQUID AT A BASIC PH, FOLLOWED BY INTERFACIAL CATALYTIC POLYMERIZATION | GENERAL ELECTRIC COMPANY (US) | 1988-04-12 | — | — | US | disclosed |
| US-4736016-A | HIGH GLASS TRANSITION TEMPERATURE | GENERAL ELECTRIC COMPANY (US) | 1988-04-05 | — | — | US | disclosed |
| EP-0257467-A2 | Composition and method for controlling polymerization rate of cyclic polycarbonate oligomers | GENERAL ELECTRIC COMPANY (US) | 1988-03-02 | — | — | EP | disclosed |
| EP-0254995-A1 | Cyclic polycarbonate oligomers from spirobiindane bisphenols | GENERAL ELECTRIC COMPANY (US) | 1988-02-03 | — | — | EP | disclosed |
| US-4722994-A | Method of preparing cyclic oligomeric polycarbonates | GENERAL ELECTRIC COMPANY (US) | 1988-02-02 | — | — | US | disclosed |
| US-4696998-A | Cyclic heterocarbonates and methods for their preparation and use | GENERAL ELECTRIC COMPANY (US) | 1987-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577391-B2 | Chemically-resistant flame retardant compositions | RPL3, RPL4, UFM1 | MEN1 4095/4885KMT2A 2027/4885ESR1 1778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.